You are on page 1of 5

Johnson & Johnson

Johnson & Johnson
Key people
Alex Gorsky, Chairman & CEO
Sushobhan Dasgupta, Managing Director, J&J (Medical) India & Vice President – Asia Pacific,
New Brunswick, NJ, USA
US$ 70.07 billion (2015)
Divisions/Verticals Consumer
Medical Devices & Diagnostics
Johnson & Johnson spread its root into India 67 years ago.
Three business segments: Consumer Healthcare, Medical Devices and Pharmaceuticals.
Consumer Healthcare
Generations of mothers in India have placed their trust in JOHNSON'S® Brand to provide
them with safe, clinically proven mild and gentle products for their babies. We also lead in
the areas of feminine hygiene, facial skincare, wound care, cough & cold, oral care among
others through iconic brands such as Stayfree®, Clean & Clear TM, BAND-AID®,
Benadryl® and Listerine®.
Medical Devices
At Johnson & Johnson Medical India, we are committed to work towards reaching our goal of
providing accessible and affordable healthcare for one person at a time. The Medical Devices
business segment produces a broad range of innovative products and solutions, in the fields
of Orthopaedics, Cardiovascular Disease, Coronary Artery Disease, Peripheral Vascular and
Obstructive Disease, Neurovascular Disease, Arrhythmias, Diabetes Care, Bariatric and
Metabolic Surgery, Cancer Surgery, Vision Care, General Surgery, Urologic Surgery, Hernia
Surgery and Infection Prevention.
Janssen, the pharmaceutical division of Johnson & Johnson, is dedicated to addressing and
solving some of the most important unmet medical needs of our time in India in oncology,
immunology, neurosciences & analgesia, dermatology, infectious diseases and metabolic
diseases in India.
At Johnson & Johnson India, we continue to be driven by a vision of caring for the people by
anticipating their needs, creating solutions and experiences that help them and those that
they care for living healthy, vibrant lives.
We also partner with UNICEF to increase knowledge, build confidence and improve
health and hygiene practices amongst adolescent girls across several states in
 Tylenol rollback in 1982 – After 7 people died due to tampering and potassium cyanide
poisoning after Tylenol reached the shelves in Chicago. Although J&J was not responsible,
conducted an immediate product recall from the entire country. Two months after the

To know more. Under the terms of the partnership. anganwadi workers. Tylenol had once again become the most popular over-the-counter analgesic in the U. Johnson & Johnson was able to remain in a positive light with the media and maintain great public relations with its swift actions. Tylenol became the first product in the industry to use a tamper resistant packaging. through its “Stayfree Women for Change” campaign has launched a unique promotional offer with the aim of encouraging women to fight anemia. Within several years.000 girls over the next three years. women users are entitled to a 50% discount on Anemia Test at any SRL Diagnostic Centre. ASHA’s and related front-line workers who play a critical role in shaping the lives of adolescent girls . The funds generated will support a pilot program on creating awareness and empowering adolescent girls in personal hygiene. They continued to make improvements in quality control. They also coupled this recovery effort with heavy ad campaigns and price promotions where you could save up to $2. Stayfree. benefitting more than 500. Campaigns: Stayfree Women for Change Did you know over 50% of women in India suffer from anemia? It can have serious health consequences on women’s lives. Tylenol was reintroduced with a new. a percentage of the proceeds from the sale of every Stayfree sanitary napkin pack will be donated to UNICEF for a period of six months starting April 2012. Even more worrying is the fact that there is low awareness of anemia and its consequences.S.Vaishali and Nalanda and in East Singhbhum and Gumla districts in Jharkhand. Johnson & Johnson’s market share had increased back up to 29%. J&J decided to reintroduce Tylenol products containing a triple-seal tamper resistant packaging. in two districts of Bihar . self-help group members. J&J developed new random inspection procedures before the shipment of Tylenol to retailers. triple-sealed package. from poor physical growth to complications in pregnancy. please call SRL Diagnostics toll free 1800 222 660 Johnson & Johnson’s “Stayfree Women for Change” and UNICEF have entered into a partnership to promote health and hygiene practices among adolescent girls in India. Television and newspaper advertisements proclaimed Tylenol as a brand you can “trust. Stayfree urges women to take an anemia test and obtain the necessary corrective action. On purchase of any Stayfree pack. [1] This new sealing design made it nearly impossible for someone to tamper with the contents without being noticed. the program will also focus on developing the knowledge and skills of teachers. if needed.” In less than a year.50 per bottle. Along with the tamper resistant packaging. Through this offer.product was removed. Building on the concept that basic hygiene is every woman’s right.

Click here to read more.” The powder primarily consists of cornstarch and talcum powder. Click here to read more. talcum powder norms in spotlight (May 2016) Claim.Fox. Post J&J verdicts. uterus. Although ovarian cancer is rare. which has to pay total compensation of $127 million in the two cases. who lived in Birmingham. What is Shower-to-Shower? Shower-to-Shower is marketed as an after-shower body powder with the slogan. 2016 — A woman who was diagnosed with ovarian cancer after using Shower-to-Shower for 10 years has filed a lawsuit (PDF) against Johnson & Johnson for failing to warn about the risk.000 will die from the disease. and into the ovaries. J&J Loses Shower-to-Shower Lawsuit in South Dakota In October 2013.$72 Million Awarded in Ovarian Cancer Lawsuit February 24. but agreed that the company failed to warn about the risk of ovarian cancer. baby powder. She died in October at age 62. the family's lawyers said. In its natural state. J&J lost a trial involving Deane Berg. Shower to Shower and Ovarian Cancer Talcum powder. Tissue samples from women with ovarian cancer have also detected talc fibers in the ovary. suggesting that talcum can move through the vagina. is a powdered mineral that is commonly found in cosmetics. The problem is that a number of recent studies have linked asbestos-free talcum powder products to an increased risk of ovarian cancer. claimed she used Baby Powder and Shower to Shower for feminine hygiene for more than 35 years before being diagnosed three years ago with ovarian cancer. “Just a sprinkle a day helps keep odor away. and more. September 14. ($72 and $55 M) . Ovarian Cancer Information The American Cancer Society estimates that 22.  two straight losses for J&J. since 1973. The jury in Sioux Falls did not award damages. negligence and conspiracy. federal law has prohibited asbestos in consumer products containing talc. talcum contains asbestos.000 women will be diagnosed with ovarian cancer this year. and over 14. an ingredient in Shower-to-Shower. Jurors found Johnson & Johnson liable for fraud. a known human carcinogen. which tends to delay diagnosis until it is difficult or impossible to cure.200 lawsuits had been filed. fallopian tubes. However. a 56 year-old woman from South Dakota who was diagnosed with ovarian cancer in 2006 after using Shower-to-Shower for 30 years. feminine hygiene products. Missouri has awarded $72 million to the family of a woman who died of ovarian cancer after using baby powder for decades as a feminine hygiene product. which help absorb moisture. Louis. Alabama. it is one of the deadliest cancers because symptoms are mild and vague. It has been sold for decades by Johnson & Johnson. 2016 — A jury in St. over 1. By February 2016.

 The last time J&J had suffered a trial loss. a Mumbai-based advocacy group set by lawyers. said that talcum powder firms should be asked to have clear instructions and if possible even have pictorial depiction for the correct use of talcum powder. causing similar cases in the US. consumer activists are talking about the lackadaisical manner the regulators https://www. Co-ordinator.  Yogini Mishra. in February 2016.  J&J is facing about 1. Scientists have found that the use of talcum powder for feminine hygiene could lead to cancer as the minute mineral particles could enter the body and get lodged in the ovaries. but more with its usage for feminine hygiene.  Consumer rights activists say they are closely monitoring the situation and waiting for the authorities to take the necessary https://www. https://www. especially baby talcum powders to avoid indiscriminate use or wrong https://www. therefore. any change in norm need to take into account baby as well as adult it was asked to pay $72 million (or Rs 475 crore) to a family of a US woman who died of cancer. Regulatory mechanism Even as the government has asked the J&J for information on the safety of its products and also asked the Bureau of Indian Standards to revise the standards for this sector. The losses faced by J&J pertain not to the talcum powder . “The government and standard setting authority BIS should take cognisance of the cases in the US and react quickly to take immediate action.” he said. Indian regulators had subsequently conducted an investigation of J&J's factory in Mulund in the city's northeast. tumor and cancer. Consumer rights activist Bejon Mishra said that the regulatory mechanism for setting standards is slow and the authorities need to be pushed to act quickly.  She said these instructions should be put in regional languages or the national language as all strata of consumers use these products. Association for Consumers Action on Safety and Other consumer advocacy groups believe there should be clear instructions on the packaging of talcum powder products.